Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AI-Powered Hepatitis C Single-Encounter Test-and-Treat
NCT07793643Phase 4Not yet recruiting
- Start
- Dec 2026
- Primary completion
- Sep 2028
- Countries
- 1
01
Overview
A Phase 4 trial of velpatasvir in hepatitis C (HCV). Planned start Dec 2026; status: not yet recruiting.
02
Drugs
velpatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT07793643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07793643.